Author: Marotta T. Bergo M. Olivecrona T.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.351, Iss.3, 1998-06, pp. : 357-361
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Hara T. Kusunoki M. Tsutsumi K. Okada K. Sakamoto S. Ohnaka M. Nakamura T. Tetsuro Miyata Nakayama K. Fukatsu A. Kato K. Kakumu S. Nakaya Y.
European Journal of Pharmacology, Vol. 350, Iss. 1, 1998-05 ,pp. :
Management of Calcium Channel Antagonist Overdose
By Salhanick S.D. Shannon M.W.
Drug Safety, Vol. 26, Iss. 2, 2003-01 ,pp. :
Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 6, 2018-11 ,pp. :
By Nishikawa M. Kubo Y. Kido H. Nakayama T. Nakamura N.
General Pharmacology, Vol. 32, Iss. 3, 1999-03 ,pp. :
By Rahalkar Amit R. Giffen Fiona Har Bryan Ho Josephine Morrison Katherine M. Hill John Wang Jian Hegele Robert A. Joy Tisha
Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 3, 2009-03 ,pp. :